学术探索
学术期刊
新闻热点
数据分析
智能评审

Induction of fetal hemoglobin in sickle cell disease

被引：38
作者：
Bunn, HF [1 ]
机构：
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
来源：
BLOOD | 1999年 / 93卷 / 06期
关键词：
D O I：
10.1182/blood.V93.6.1787.406a34_1787_1789
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1787 / 1789
页数：3
相关论文
共 24 条
  • [1] Atweh GF, 1999, BLOOD, V93, P1790
  • [2] EFFECT OF HYDROXYUREA ON THE RHEOLOGICAL PROPERTIES OF SICKLE ERYTHROCYTES INVIVO
    BALLAS, SK
    DOVER, GJ
    CHARACHE, S
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1989, 32 (02) : 104 - 111
  • [3] A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy
    Bridges, KR
    Barabino, GD
    Brugnara, C
    Cho, MR
    Christoph, GW
    Dover, G
    Ewenstein, BM
    Golan, DE
    Guttmann, CRG
    Hofrichter, J
    Mulkern, RV
    Zhang, B
    Eaton, WA
    [J]. BLOOD, 1996, 88 (12) : 4701 - 4710
  • [4] Mechanisms of disease - Pathogenesis and treatment of sickle cell disease
    Bunn, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 762 - 769
  • [5] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA
    CHARACHE, S
    TERRIN, ML
    MOORE, RD
    DOVER, GJ
    BARTON, FB
    ECKERT, SV
    MCMAHON, RP
    BONDS, DR
    ORRINGER, E
    JONES, S
    STRAYHORN, D
    ROSSE, W
    PHILLIPS, G
    PEACE, D
    JOHNSONTELFAIR, A
    MILNER, P
    KUTLAR, A
    TRACY, A
    BALLAS, SK
    ALLEN, GE
    MOSHANG, J
    SCOTT, B
    STEINBERG, M
    ANDERSON, A
    SABAHI, V
    PEGELOW, C
    TEMPLE, D
    CASE, E
    HARRELL, R
    CHILDERIE, S
    EMBURY, S
    SCHMIDT, B
    DAVIES, D
    KOSHY, M
    TALISCHYZAHED, N
    DORN, L
    PENDARVIS, G
    MCGEE, M
    TELFER, M
    DAVIS, A
    CASTRO, O
    FINKE, H
    PERLIN, E
    SITEMAN, J
    GASCON, P
    DIPAOLO, P
    GARGIULO, S
    ECKMAN, J
    BAILEY, JH
    PLATT, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) : 1317 - 1322
  • [6] CHARACHE S, 1987, BLOOD, V69, P109
  • [7] Hydroxyurea and sickle cell anemia - Clinical utility of a myelosuppressive ''switching'' agent
    Charache, S
    Barton, FB
    Moore, RD
    Terrin, ML
    Steinberg, MH
    Dover, GJ
    Ballas, SK
    McMahon, RP
    Castro, O
    Orringer, EP
    Jones, S
    Strayhorn, D
    Rosse, W
    Phillips, G
    Peace, D
    JohnsonTelfair, A
    Milner, P
    Kutlar, A
    Tracy, A
    Allen, GE
    Moshang, J
    Steinberg, M
    Anderson, A
    Sabahi, V
    Pegelow, C
    Temple, D
    Case, E
    Harrell, R
    Embury, S
    Schmidt, B
    Koshy, M
    TalischyZahed, N
    Dorn, L
    Pendarvis, G
    McGee, M
    Telfer, M
    Davis, A
    Finke, H
    Perlin, E
    Siteman, J
    Gascon, P
    diPaolo, P
    Gargiulo, S
    Eckman, J
    Bailey, JH
    Platt, A
    Waller, L
    Ramirez, G
    Knors, V
    Hernandez, S
    [J]. MEDICINE, 1996, 75 (06) : 300 - 326
  • [8] CONSTANTOULAKIS P, 1989, BLOOD, V74, P1963
  • [9] THE BIOPHYSICS OF SICKLE-CELL HYDROXYUREA THERAPY
    EATON, WA
    HOFRICHTER, J
    [J]. SCIENCE, 1995, 268 (5214) : 1142 - 1143
  • [10] Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial
    Ferster, A
    Vermylen, C
    Cornu, G
    Buyse, M
    Corazza, F
    Devalck, C
    Fondu, P
    Toppet, M
    Sariban, E
    [J]. BLOOD, 1996, 88 (06) : 1960 - 1964
123